ArticleMolecular systems biology2026
Interpretable multi-omics integration across mixed-order tensors with MANTRA.
Article in Molecular systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The integration of multi-modal molecular data is crucial for understanding complex diseases, but existing methods struggle with modern experimental designs that generate datasets with mixed-order tensors-for example, a third-order drug-response tensor alongside a second-order transcriptomics matrix. Here, we present MANTRA (Multi-view ANalysis with Tensor and matRix Alignment), a probabilistic framework that integrates collections of tensors of different orders, combining the strengths of group factor analysis and tensor decomposition. MANTRA learns interpretable latent factors and naturally handles missing data through a Bayesian approach with structured sparsity priors. On a Chronic Lymphocytic Leukemia (CLL) dataset, the joint analysis of a third-order drug-response tensor and a second-order RNA-seq matrix with MANTRA revealed clinically relevant patient subgroups that were missed by single-view or matrix-based analyses. In a single-cell multi-omics study of Acute Lymphoblastic Leukemia (ALL), MANTRA identified a novel patient subgroup defined by a distinct molecular program in plasmacytoid dendritic cells (pDCs), linking disease heterogeneity to a specific cell type. By explicitly modeling higher- order data structures, MANTRA provides an interpretable tool to uncover hidden biological variation from complex experimental data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.